Clinical Trials Directory

Trials / Unknown

UnknownNCT00941382

Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese Patients

Double-blind, Randomized Clinical Trial to Evaluate Effect of Combination Therapy of Metformin and Sibutramine Versus Metformin or Sibutramine Monotherapy Over Weight, Adiposity, Glucose Metabolism and Inflammatory State in Obese Patients

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Laboratorios Silanes S.A. de C.V. · Industry
Sex
All
Age
30 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the effect of sibutramine and metformin combination therapy in comparison with sibutramine or metformin monotherapy over weight, adiposity, glucose metabolism and inflammatory state in obese patients.

Detailed description

The treatment of obesity is strongly recommended because it exacerbates insulin resistance, hypertension, dyslipidemia and atherosclerosis, and represents a risk factor for type 2 diabetes. Although diet and exercise are valuable in this treatment, patient compliance is a major problem. Sibutramine has been shown to be a highly effective pharmacotherapy for weigh loss in obese patients, mediated by increased satiety and an enhancement of energy expenditure. Metformin is widely used for glycemia control and is associated with a small to moderate body weight loss. We are assessing the combination of sibutramine and metformin, two agents with different mechanisms of action for control of body weight and metabolic dysregulation.

Conditions

Interventions

TypeNameDescription
DRUGSibutramine-Metforminsibutramine and metformin, 15 mg per day and 850 mg per day, respectively, in a single tablet, for 180 days
DRUGSibutramine15 mg per day for 180 days
DRUGMetforminMetformin 850 mg per day for 180 days

Timeline

Start date
2008-11-01
Primary completion
2009-08-01
Completion
2009-09-01
First posted
2009-07-17
Last updated
2009-07-17

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT00941382. Inclusion in this directory is not an endorsement.